Doxercalciferol
98%
- Product Code: 110856
CAS:
54573-75-0
| Molecular Weight: | 412.65 g./mol | Molecular Formula: | C₂₈H₄₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00871065 | |
| Melting Point: | 138-140°C | Boiling Point: | |
| Density: | Storage Condition: | -20°C |
Product Description:
Doxercalciferol is primarily used in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease who are undergoing dialysis. It helps to regulate calcium and phosphorus levels in the blood by suppressing the secretion of parathyroid hormone, which can become elevated in kidney disease. This action helps to prevent bone disease and other complications associated with abnormal mineral metabolism. Additionally, doxercalciferol is sometimes used in the management of vitamin D deficiency in patients who cannot adequately convert vitamin D to its active form. Its use is carefully monitored to avoid potential side effects such as hypercalcemia or hyperphosphatemia.
Product Specification:
| Test | Specification |
|---|---|
| Purity (HPLC) | 98-100 |
| Appearance | White To Off-White Powder Or Solid Or Chunks |
| Infrared Spectrometry | Conforms To Structure |
| Proton NMR Spectrum | Conforms To Structure |
| Solubility | >10 Mg/Ml In DMSO |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $155.92 |
+
-
|
| 0.005 | 10-20 days | $323.58 |
+
-
|
Doxercalciferol
Doxercalciferol is primarily used in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease who are undergoing dialysis. It helps to regulate calcium and phosphorus levels in the blood by suppressing the secretion of parathyroid hormone, which can become elevated in kidney disease. This action helps to prevent bone disease and other complications associated with abnormal mineral metabolism. Additionally, doxercalciferol is sometimes used in the management of vitamin D deficiency in patients who cannot adequately convert vitamin D to its active form. Its use is carefully monitored to avoid potential side effects such as hypercalcemia or hyperphosphatemia.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :